Long-term outcomes after robotic-assisted Ivor Lewis esophagectomy.
Esophageal cancer
Esophagectomy
Ivor Lewis
Robotic
Survival
Journal
Journal of robotic surgery
ISSN: 1863-2491
Titre abrégé: J Robot Surg
Pays: England
ID NLM: 101300401
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
25
01
2021
accepted:
20
02
2021
pubmed:
28
2
2021
medline:
25
2
2022
entrez:
27
2
2021
Statut:
ppublish
Résumé
Robotic assistance has gained acceptance in thoracic procedures, including esophagectomy. There is a paucity of data regarding long-term outcomes for robotic esophagectomy. We previously reported our initial series of robot-assisted Ivor Lewis (RAIL) esophagectomy. We report long-term outcomes to assess the efficacy of the procedure. We performed a retrospective review of 112 consecutive patients who underwent a RAIL. Patient demographics, diagnosis, pathology, operative characteristics, post-operative complications, and long-term outcomes were documented. Descriptive statistical analysis was performed for all the variables. Primary endpoints were mortality and disease-free survival. Overall survival (OS) and disease-free survival (DFS) were calculated using the Kaplan-Meier method. Of the 112 patients, 106 had a diagnosis of cancer, with adenocarcinoma the dominant histology (87.5%). Of these 106 patients, 81 (76.4%) received neo-adjuvant chemoradiation. The 30-, 60-, and 90-day mortality was 1 (0.9%), 3 (2.7%), and 4 (3.6%), respectively. There were 9 anastomotic leaks (8%) and 18 (16.1%) patients had a stricture requiring dilation. All-patient OS at 1, 3, and 5 years was 81.4%, 60.5%, and 51.0%, respectively. For cancer patients, the 1-, 3-, and 5-year OS was 81.3%, 59.2%, and 49.4%, respectively, and the DFS was 75.3%, 42.3%, and 44.0%. We have shown that long-term outcomes after RAIL esophagectomy are similar to other non-robotic esophagectomies. Given the potential advantages of robotic assistance, our results are crucial to demonstrate that RAIL does not result in inferior outcomes.
Identifiants
pubmed: 33638759
doi: 10.1007/s11701-021-01219-2
pii: 10.1007/s11701-021-01219-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
119-125Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag London Ltd. part of Springer Nature.
Références
Domper Arnal MJ, Ferrandez Arenas A, Lanas AA (2015) Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol 21(26):7933–7943
doi: 10.3748/wjg.v21.i26.7933
Gockel I, Heckhoff S, Messow CM, Kneist W, Junginger T (2005) Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: does the operative approach have an influence on the long-term prognosis? World J Surg Oncol 3:40
doi: 10.1186/1477-7819-3-40
van Workum F, Berkelmans GH, Klarenbeek BR, Nieuwenhuijzen GAP, Luyer MDP, Rosman C (2017) McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: systematic review and meta-analysis. J Thorac Dis 9(Suppl 8):S826–S833
doi: 10.21037/jtd.2017.03.173
Haverkamp L, Seesing MF, Ruurda JP, Boone J, Hillegersberg RV (2017) Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer. Dis Esophagus 30(1):1–7
pubmed: 27001442
Ruurda JP, van der Sluis PC, van der Horst S, van Hilllegersberg R (2015) Robot-assisted minimally invasive esophagectomy for esophageal cancer: a systematic review. J Surg Oncol 112(3):257–265
doi: 10.1002/jso.23922
D’Amico TA (2006) Robotics in thoracic surgery: applications and outcomes. J Thorac Cardiovasc Surg 131(1):19–20
doi: 10.1016/j.jtcvs.2005.09.007
Weksler B, Sharma P, Moudgill N, Chojnacki KA, Rosato EL (2012) Robot-assisted minimally invasive esophagectomy is equivalent to thoracoscopic minimally invasive esophagectomy. Dis Esophagus 25(5):403–409
doi: 10.1111/j.1442-2050.2011.01246.x
van der Sluis PC, van der Horst S, May AM et al (2019) Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial. Ann Surg 269(4):621–630
doi: 10.1097/SLA.0000000000003031
Hodari A, Park KU, Lace B, Tsiouris A, Hammoud Z (2015) Robot-assisted minimally invasive Ivor Lewis esophagectomy with real-time perfusion assessment. Ann Thorac Surg 100(3):947–952
doi: 10.1016/j.athoracsur.2015.03.084
van der Sluis PC, Ruurda JP, Verhage RJ et al (2015) Oncologic long-term results of robot-assisted minimally invasive thoraco-laparoscopic esophagectomy with two-field lymphadenectomy for esophageal cancer. Ann Surg Oncol 22(Suppl 3):S1350–S1356
doi: 10.1245/s10434-015-4544-x
Galvani CA, Gorodner MV, Moser F et al (2008) Robotically assisted laparoscopic transhiatal esophagectomy. Surg Endosc 22(1):188–195
doi: 10.1007/s00464-007-9441-3
Cerfolio RJ, Bryant AS, Hawn MT (2013) Technical aspects and early results of robotic esophagectomy with chest anastomosis. J Thorac Cardiovasc Surg 145(1):90–96
doi: 10.1016/j.jtcvs.2012.04.022
Kim DJ, Park SY, Lee S, Kim HI, Hyung WJ (2014) Feasibility of a robot-assisted thoracoscopic lymphadenectomy along the recurrent laryngeal nerves in radical esophagectomy for esophageal squamous carcinoma. Surg Endosc 28(6):1866–1873
doi: 10.1007/s00464-013-3406-5
Suda K, Ishida Y, Kawamura Y et al (2012) Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes. World J Surg 36(7):1608–1616
doi: 10.1007/s00268-012-1538-8
Shridhar R, Abbott AM, Doepker M, Hoffe SE, Almhanna K, Meredith KL (2016) Perioperative outcomes associated with robotic Ivor Lewis esophagectomy in patient’s undergoing neoadjuvant chemoradiotherapy. J Gastrointest Oncol 7(2):206–212
pubmed: 27034787
pmcid: 4783744
Puntambekar SP, Rayate N, Joshi S, Agarwal G (2011) Robotic transthoracic esophagectomy in the prone position: experience with 32 patients with esophageal cancer. J Thorac Cardiovasc Surg 142(5):1283–1284
doi: 10.1016/j.jtcvs.2011.03.028
Kernstine KH, DeArmond DT, Shamoun DM, Campos JH (2007) The first series of completely robotic esophagectomies with three-field lymphadenectomy: initial experience. Surg Endosc 21(12):2285–2292
doi: 10.1007/s00464-007-9405-7
Hanaoka N, Ishihara R, Motoori M et al (2018) Endoscopic balloon dilation followed by intralesional steroid injection for anastomotic strictures after esophagectomy: a randomized controlled trial. Am J Gastroenterol 113(10):1468–1474
doi: 10.1038/s41395-018-0253-y
Sutcliffe RP, Forshaw MJ, Tandon R et al (2008) Anastomotic strictures and delayed gastric emptying after esophagectomy: incidence, risk factors and management. Dis Esophagus 21(8):712–717
doi: 10.1111/j.1442-2050.2008.00865.x
van Heijl M, Gooszen JA, Fockens P, Busch OR, van Lanschot JJ, van Berge Henegouwen MI (2010) Risk factors for development of benign cervical strictures after esophagectomy. Ann Surg 251(6):1064–1069
doi: 10.1097/SLA.0b013e3181deb4b7
Dunn DH, Johnson EM, Morphew JA, Dilworth HP, Krueger JL, Banerji N (2013) Robot-assisted transhiatal esophagectomy: a 3-year single-center experience. Dis Esophagus 26(2):159–166
doi: 10.1111/j.1442-2050.2012.01325.x
Martin JT, Federico JA, McKelvey AA, Kent MS, Fabian T (2009) Prevention of delayed gastric emptying after esophagectomy: a single center’s experience with botulinum toxin. Ann Thorac Surg 87(6):1708–1713 (discussion 13-4)
doi: 10.1016/j.athoracsur.2009.01.075
Lee HS, Kim MS, Lee JM, Kim SK, Kang KW, Zo JI (2005) Intrathoracic gastric emptying of solid food after esophagectomy for esophageal cancer. Ann Thorac Surg 80(2):443–447
doi: 10.1016/j.athoracsur.2005.02.049
Glatz T, Marjanovic G, Kulemann B, Sick O, Hopt UT, Hoeppner J (2017) Hybrid minimally invasive esophagectomy vs. open esophagectomy: a matched case analysis in 120 patients. Langenbecks Arch Surg 402(2):323–331
doi: 10.1007/s00423-017-1550-4
Zhang L, Hou SC, Miao JB, Lee H (2017) Risk factors for delayed gastric emptying in patients undergoing esophagectomy without pyloric drainage. J Surg Res 213:46–50
doi: 10.1016/j.jss.2017.02.012
Fuchs HF, Harnsberger CR, Broderick RC et al (2017) Mortality after esophagectomy is heavily impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample. Surg Endosc 31(6):2491–2497
doi: 10.1007/s00464-016-5251-9
Luketich JD, Pennathur A, Awais O et al (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256(1):95–103
doi: 10.1097/SLA.0b013e3182590603
Seesing MFJ, Gisbertz SS, Goense L et al (2017) A Propensity score matched analysis of open versus minimally invasive transthoracic esophagectomy in the Netherlands. Ann Surg 266(5):839–846
doi: 10.1097/SLA.0000000000002393
Espinoza-Mercado F, Imai TA, Borgella JD et al (2018) Does the approach matter? Comparing survival in robotic, minimally invasive and open esophagectomies. Ann Thorac Surg 107:378–385
doi: 10.1016/j.athoracsur.2018.08.039
He H, Wu Q, Wang Z et al (2018) Short-term outcomes of robot-assisted minimally invasive esophagectomy for esophageal cancer: a propensity score matched analysis. J Cardiothorac Surg 13(1):52
doi: 10.1186/s13019-018-0727-4
Worni M, Martin J, Gloor B et al (2012) Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008. J Am Coll Surg 215(5):643–651
doi: 10.1016/j.jamcollsurg.2012.07.006
van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084
doi: 10.1056/NEJMoa1112088
Shapiro J, van Lanschot JJB, Hulshof M et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16(9):1090–1098
doi: 10.1016/S1470-2045(15)00040-6
Woodard GA, Crockard JC, Clary-Macy C et al (2016) Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity. J Surg Oncol 114(7):838–847
doi: 10.1002/jso.24409
Lubbers M, van Det MJ, Kreuger MJ et al (2018) Totally minimally invasive esophagectomy after neoadjuvant chemoradiotherapy: long-term oncologic outcomes. J Surg Oncol 117(4):651–658
doi: 10.1002/jso.24935
Tapias LF, Mathisen DJ, Wright CD et al (2016) Outcomes with open and minimally invasive Ivor Lewis esophagectomy after neoadjuvant therapy. Ann Thorac Surg 101(3):1097–1103
doi: 10.1016/j.athoracsur.2015.09.062